( June 29, 2026, 9:05 AM EDT) -- WASHINGTON, D.C. — A California-based e-liquid manufacturer filed a petitioner’s brief to the D.C. Circuit U.S. Court of Appeals arguing that the Food and Drug Administration’s ban of its products, which it claims will hurt its business and cause it irreparable harm, was arbitrary and capricious because it was based on an incorrect and unfairly adopted definition of what should be considered appropriate for the protection of public health....